Trivarx Ltd (MDBIF)

[StockRoomBully]

Medibio David Kaysen interview


"We certainly see 2019 as a year of commercialization. As I mentioned, we’re working on 510(k) filings and commercialization strategy will align with these specific indications for use. At the same time, we continue development of our technology platform that will focus on other indications that have
and we will continue to evaluate and refine that business model."

https://medicalalley.org/2019/01/6-questions-on-the-future-of-healthcare-with-david-kaysen/?preview=true&_thumbnail_id=130652&utm_source=newsletter&utm_medium=Email&utm_campaign=Jan21